Holdings of Health Care Fund
Rydex Series Funds · Original filing · Compare with another fund · Report an error
- Net assets
- 19.4M $ including 16.2M $ in equities, 83.2 %
- Positions
- 130 in 9 countries
- Top ten
- 20.6 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 588 | 705.3K $ | 3.63 % |
| 2 | Johnson & Johnson | 2,203 | 559.5K $ | 2.88 % |
| 3 | AbbVie Inc | 1,945 | 489.4K $ | 2.52 % |
| 4 | UnitedHealth Group Inc | 1,037 | 431K $ | 2.22 % |
| 5 | Merck & Co Inc | 3,083 | 396.2K $ | 2.04 % |
| 6 | Thermo Fisher Scientific Inc | 622 | 311.8K $ | 1.61 % |
| 7 | Amgen Inc | 835 | 302.4K $ | 1.56 % |
| 8 | Abbott Laboratories | 3,030 | 274.9K $ | 1.42 % |
| 9 | Gilead Sciences Inc | 2,132 | 269.4K $ | 1.39 % |
| 10 | Vertex Pharmaceuticals Inc | 522 | 259.3K $ | 1.34 % |
| 11 | CVS Health Corp | 2,459 | 254.4K $ | 1.31 % |
| 12 | Intuitive Surgical Inc | 639 | 254.1K $ | 1.31 % |
| 13 | Danaher Corp | 1,326 | 252.6K $ | 1.30 % |
| 14 | Pfizer Inc | 10,090 | 243K $ | 1.25 % |
| 15 | Bristol-Myers Squibb Co | 4,101 | 236.3K $ | 1.22 % |
| 16 | Stryker Corp | 747 | 235.2K $ | 1.21 % |
| 17 | McKesson Corp | 270 | 204K $ | 1.05 % |
| 18 | Elevance Health Inc | 514 | 198.8K $ | 1.02 % |
| 19 | Cigna Group/The | 659 | 181.7K $ | 0.94 % |
| 20 | Regeneron Pharmaceuticals Inc | 281 | 175.2K $ | 0.90 % |
| 21 | HCA Healthcare Inc | 435 | 169.6K $ | 0.87 % |
| 22 | Cardinal Health Inc | 702 | 166.8K $ | 0.86 % |
| 23 | Boston Scientific Corp | 3,902 | 166.5K $ | 0.86 % |
| 24 | Edwards Lifesciences Corp | 1,794 | 162.3K $ | 0.84 % |
| 25 | Novo Nordisk A/S | 3,350 | 160.6K $ | 0.83 % |
| 26 | Cencora Inc | 562 | 159K $ | 0.82 % |
| 27 | Humana Inc | 394 | 156.5K $ | 0.81 % |
| 28 | Medtronic PLC | 1,925 | 150.6K $ | 0.78 % |
| 29 | NATERA INC | 553 | 150.1K $ | 0.77 % |
| 30 | REVOLUTION MEDICINES INC | 793 | 148.5K $ | 0.76 % |
| 31 | Becton Dickinson & Co | 952 | 144.1K $ | 0.74 % |
| 32 | ICON PLC | 821 | 142.6K $ | 0.73 % |
| 33 | ALNYLAM PHARMACEUTICALS INC | 469 | 141.2K $ | 0.73 % |
| 34 | Agilent Technologies Inc | 1,040 | 138.1K $ | 0.71 % |
| 35 | Waters Corp | 366 | 137.3K $ | 0.71 % |
| 36 | IDEXX Laboratories Inc | 258 | 135.8K $ | 0.70 % |
| 37 | Argenx SE | 145 | 134.5K $ | 0.69 % |
| 38 | BEONE MEDICINES LTD | 457 | 130.2K $ | 0.67 % |
| 39 | JAZZ PHARMACEUTICALS PLC | 539 | 129.9K $ | 0.67 % |
| 40 | IQVIA Holdings Inc | 667 | 128.9K $ | 0.66 % |
| 41 | MODERNA INC | 1,838 | 128.7K $ | 0.66 % |
| 42 | Biogen Inc | 590 | 127.5K $ | 0.66 % |
| 43 | Centene Corp | 1,962 | 125.9K $ | 0.65 % |
| 44 | Alkermes PLC | 2,400 | 125.7K $ | 0.65 % |
| 45 | ROYALTY PHARMA PLC | 2,150 | 120.6K $ | 0.62 % |
| 46 | Mettler-Toledo International Inc | 93 | 118.8K $ | 0.61 % |
| 47 | GE HealthCare Technologies Inc | 1,842 | 117.9K $ | 0.61 % |
| 48 | Veeva Systems Inc | 664 | 117.8K $ | 0.61 % |
| 49 | ResMed Inc | 600 | 116.9K $ | 0.60 % |
| 50 | Illumina Inc | 659 | 115.9K $ | 0.60 % |
| 51 | AstraZeneca PLC | 611 | 115.9K $ | 0.60 % |
| 52 | West Pharmaceutical Services Inc | 321 | 115.2K $ | 0.59 % |
| 53 | Teva Pharmaceutical Industries Ltd | 3,388 | 114.8K $ | 0.59 % |
| 54 | GSK PLC | 2,172 | 113.9K $ | 0.59 % |
| 55 | CRISPR Therapeutics AG | 2,051 | 111.9K $ | 0.58 % |
| 56 | BioNTech SE | 1,196 | 111.3K $ | 0.57 % |
| 57 | Quest Diagnostics Inc | 512 | 108.5K $ | 0.56 % |
| 58 | Labcorp Holdings Inc | 387 | 108.4K $ | 0.56 % |
| 59 | Novartis AG | 688 | 107.8K $ | 0.56 % |
| 60 | Zoetis Inc | 1,499 | 107.7K $ | 0.55 % |
| 61 | Insmed Inc | 1,006 | 107.3K $ | 0.55 % |
| 62 | Dexcom Inc | 1,567 | 105.5K $ | 0.54 % |
| 63 | United Therapeutics Corp | 191 | 103.5K $ | 0.53 % |
| 64 | GUARDANT HEALTH INC | 687 | 103.1K $ | 0.53 % |
| 65 | Ascendis Pharma A/S | 386 | 103K $ | 0.53 % |
| 66 | Alcon AG | 1,502 | 100.8K $ | 0.52 % |
| 67 | STERIS PLC | 475 | 100K $ | 0.52 % |
| 68 | Roivant Sciences Ltd | 2,808 | 99.4K $ | 0.51 % |
| 69 | Incyte Corp | 855 | 96.9K $ | 0.50 % |
| 70 | VIATRIS INC | 5,858 | 93K $ | 0.48 % |
| 71 | Neurocrine Biosciences Inc | 542 | 91.3K $ | 0.47 % |
| 72 | Zimmer Biomet Holdings Inc | 1,036 | 89.2K $ | 0.46 % |
| 73 | TENET HEALTHCARE CORP | 475 | 88.9K $ | 0.46 % |
| 74 | Cooper Cos Inc/The | 1,179 | 84.5K $ | 0.44 % |
| 75 | Molina Healthcare Inc | 366 | 83.7K $ | 0.43 % |
| 76 | Bio-Techne Corp | 1,178 | 83.2K $ | 0.43 % |
| 77 | Bridgebio Pharma Inc | 1,113 | 82.9K $ | 0.43 % |
| 78 | IONIS PHARMACEUTICALS INC | 1,022 | 81K $ | 0.42 % |
| 79 | CYTOKINETICS INC | 949 | 80.8K $ | 0.42 % |
| 80 | Revvity Inc | 726 | 80.8K $ | 0.42 % |
| 81 | Exelixis Inc | 1,465 | 79.7K $ | 0.41 % |
| 82 | Charles River Laboratories International Inc | 350 | 79.4K $ | 0.41 % |
| 83 | ELANCO ANIMAL HEALTH INC | 3,112 | 76.6K $ | 0.39 % |
| 84 | Medpace Holdings Inc | 142 | 75.2K $ | 0.39 % |
| 85 | Arrowhead Pharmaceuticals Inc | 918 | 74.8K $ | 0.39 % |
| 86 | BioMarin Pharmaceutical Inc | 1,298 | 74.3K $ | 0.38 % |
| 87 | Align Technology Inc | 438 | 73.9K $ | 0.38 % |
| 88 | Baxter International Inc | 3,464 | 73.9K $ | 0.38 % |
| 89 | Insulet Corp | 472 | 71.9K $ | 0.37 % |
| 90 | Ensign Group Inc/The | 440 | 70.5K $ | 0.36 % |
| 91 | Halozyme Therapeutics Inc | 897 | 70.2K $ | 0.36 % |
| 92 | VAXCYTE INC | 1,192 | 69.3K $ | 0.36 % |
| 93 | Axsome Therapeutics Inc | 279 | 68.3K $ | 0.35 % |
| 94 | Krystal Biotech Inc | 182 | 67.6K $ | 0.35 % |
| 95 | Hims & Hers Health Inc | 1,892 | 65.6K $ | 0.34 % |
| 96 | TG THERAPEUTICS INC | 1,182 | 64.9K $ | 0.33 % |
| 97 | Universal Health Services Inc | 434 | 64.5K $ | 0.33 % |
| 98 | Henry Schein Inc | 763 | 63.7K $ | 0.33 % |
| 99 | Protagonist Therapeutics Inc | 517 | 63.4K $ | 0.33 % |
| 100 | Corcept Therapeutics Inc | 722 | 62.8K $ | 0.32 % |
Sector breakdown
- Health care 67.3 %
- Technology 0.7 %
- Unattributed 32.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 90.3 %
- Ireland 2.5 %
- Denmark 1.6 %
- United Kingdom 1.4 %
- Switzerland 1.3 %
- Netherlands 0.8 %
- Israel 0.7 %
- Germany 0.7 %
- Bermuda 0.6 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 117 | 14.6M $ | 90.33 % |
| 2 | Ireland | 3 | 398.2K $ | 2.46 % |
| 3 | Denmark | 2 | 263.6K $ | 1.63 % |
| 4 | United Kingdom | 2 | 229.7K $ | 1.42 % |
| 5 | Switzerland | 2 | 212.6K $ | 1.32 % |
| 6 | Netherlands | 1 | 134.5K $ | 0.83 % |
| 7 | Israel | 1 | 114.8K $ | 0.71 % |
| 8 | Germany | 1 | 111.3K $ | 0.69 % |
| 9 | Bermuda | 1 | 99.4K $ | 0.61 % |
Cite this page
Titelia. "Holdings of Health Care Fund". https://titelia.com/en/funds/S000003808